How does WIPO Standard ST.26 define “unknown” or “other” nucleotides and amino acids?
MPEP 2412.03(a) refers to WIPO Standard ST.26, which defines “unknown” or “other” nucleotides and amino acids using specific symbols: For nucleotides, the symbol “n” represents “unknown” or “other” For amino acids, the symbol “X” represents “unknown” or “other” The MPEP provides tables for both nucleotide and amino acid symbols, stating: n a or c or…
Read MoreWhich nucleotides are considered “specifically defined” according to WIPO Standard ST.26?
According to MPEP 2412.03(a), WIPO Standard ST.26 defines “specifically defined” nucleotides as any nucleotide other than those represented by the symbol “n”. The MPEP provides a table of nucleotide symbols, where: Symbols a, c, g, and t/u represent specifically defined nucleotides Symbols like m, r, w, s, y, k, v, h, d, and b represent…
Read MoreWhat does “specifically defined” mean in the context of nucleotide and amino acid sequences?
According to MPEP 2412.03(a), “specifically defined” refers to any amino acid or nucleotide as defined in paragraph 3(k) of WIPO Standard ST.26. The MPEP states: “Specifically defined” means any amino acid or nucleotide as defined in paragraph 3(k) of WIPO Standard ST.26. This definition applies to patent applications filed on or after July 1, 2022,…
Read MoreWhat amino acids are considered “specifically defined” according to WIPO Standard ST.26?
MPEP 2412.03(a) refers to WIPO Standard ST.26, which defines “specifically defined” amino acids as any amino acid other than those represented by the symbol “X”. The MPEP provides a table of amino acid symbols, where: Single-letter symbols A, R, N, D, C, Q, E, G, H, I, L, K, M, F, P, O, S, U,…
Read MoreWhen did the new requirements for “specifically defined” nucleotides and amino acids come into effect?
According to MPEP 2412.03(a), the new requirements for “specifically defined” nucleotides and amino acids came into effect for patent applications filed on or after July 1, 2022. The MPEP states: [Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as…
Read More